{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T14:01:48Z","timestamp":1791900108440,"version":"4.3.4"},"reference-count":176,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T00:00:00Z","timestamp":1695427200000},"content-version":"am","delay-in-days":326,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004156","name":"Mahidol University","doi-asserted-by":"publisher","award":["NDFR 13\/2564"],"award-info":[{"award-number":["NDFR 13\/2564"]}],"id":[{"id":"10.13039\/501100004156","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.lfs.2022.120986","type":"journal-article","created":{"date-parts":[[2022,9,21]],"date-time":"2022-09-21T12:56:45Z","timestamp":1663765005000},"page":"120986","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"special_numbering":"C","title":["Cdk5-p25 as a key element linking amyloid and tau pathologies in Alzheimer's disease: Mechanisms and possible therapeutic interventions"],"prefix":"10.1016","volume":"308","author":[{"given":"Subhamita","family":"Maitra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Vincent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.lfs.2022.120986_bb0005","doi-asserted-by":"crossref","first-page":"843","DOI":"10.3233\/JAD-180792","article-title":"CDK5: A unique CDK and its multiple roles in the nervous system","volume":"68","author":"Cort\u00e9s","year":"2019","journal-title":"J. Alzheimers Dis."},{"issue":"22","key":"10.1016\/j.lfs.2022.120986_bb0010","doi-asserted-by":"crossref","first-page":"10867","DOI":"10.1073\/pnas.89.22.10867","article-title":"Neuronal cdc2-like kinase: a cdc2-related protein kinase with predominantly neuronal expression","volume":"89","author":"Hellmich","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6496","key":"10.1016\/j.lfs.2022.120986_bb0015","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/371423a0","article-title":"A brain-specific activator of cyclin-dependent kinase 5","volume":"371","author":"Lew","year":"1994","journal-title":"Nature"},{"issue":"6496","key":"10.1016\/j.lfs.2022.120986_bb0020","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/371419a0","article-title":"p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5","volume":"371","author":"Tsai","year":"1994","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.lfs.2022.120986_bb0025","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1073\/pnas.93.8.3259","article-title":"The brain-specific activator p35 allows Cdk5 to escape inhibition by p27Kip1 in neurons","volume":"93","author":"Lee","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"37","key":"10.1016\/j.lfs.2022.120986_bb0030","doi-asserted-by":"crossref","first-page":"24057","DOI":"10.1074\/jbc.273.37.24057","article-title":"p35, the neuronal-specific activator of cyclin-dependent kinase 5 (Cdk5) is degraded by the ubiquitin-proteasome pathway","volume":"273","author":"Patrick","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.lfs.2022.120986_bb0035","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/jnr.10116","article-title":"Cdk5-p35-basic cyclin-dependent kinase 5 (cdk5) activation requires interaction with three domains of p35","volume":"67","author":"Amin","year":"2002","journal-title":"J. Neurosci. Res."},{"issue":"18","key":"10.1016\/j.lfs.2022.120986_bb0040","doi-asserted-by":"crossref","first-page":"14052","DOI":"10.1074\/jbc.M109.068262","article-title":"Cdk5 nuclear localization is p27-dependent in nerve cells. Implications for cell cycle suppression and caspase-3 activation","volume":"285","author":"Zhang","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.lfs.2022.120986_bb0045","doi-asserted-by":"crossref","first-page":"C339","DOI":"10.1152\/ajpcell.00168.2014","article-title":"Cyclin I and p35 determine the subcellular distribution of Cdk5","volume":"308","author":"Hagmann","year":"2015","journal-title":"Am. J. Physiol. Cell. Physiol."},{"issue":"7","key":"10.1016\/j.lfs.2022.120986_bb0050","doi-asserted-by":"crossref","first-page":"4328","DOI":"10.1007\/s12035-015-9369-x","article-title":"The role of Cdk5 in Alzheimer\u2019s disease","volume":"53","author":"Liu","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.lfs.2022.120986_bb0055","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.brainresbull.2017.05.006","article-title":"Cyclin dependent kinase 5: a novel avenue for Alzheimer's disease","volume":"132","author":"Bhounsule","year":"2017","journal-title":"Brain Res. Bull."},{"issue":"6762","key":"10.1016\/j.lfs.2022.120986_bb0060","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/45159","article-title":"Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration","volume":"402","author":"Patrick","year":"1999","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.lfs.2022.120986_bb0065","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1101\/gad.10.7.816","article-title":"The cdk5\/p35 kinase is essential for neurite outgrowth during neuronal differentiation","volume":"10","author":"Nikolic","year":"1996","journal-title":"Genes Dev."},{"issue":"6","key":"10.1016\/j.lfs.2022.120986_bb0070","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1111\/j.1471-4159.2005.03301.x","article-title":"Activation of latent cyclin-dependent kinase 5 (Cdk5)-p35 complexes by membrane dissociation","volume":"94","author":"Zhu","year":"2005","journal-title":"J. Neurochem."},{"issue":"7","key":"10.1016\/j.lfs.2022.120986_bb0075","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1091\/mbc.e07-11-1106","article-title":"Novel genetic tools reveal Cdk5\u2019s major role in golgi fragmentation in Alzheimer\u2019s disease","volume":"19","author":"Sun","year":"2008","journal-title":"Mol. Biol. Cell"},{"issue":"25","key":"10.1016\/j.lfs.2022.120986_bb0080","doi-asserted-by":"crossref","first-page":"8772","DOI":"10.1073\/pnas.0711355105","article-title":"Nuclear localization of Cdk5 is a key determinant in the postmitotic state of neurons","volume":"105","author":"Zhang","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"14","key":"10.1016\/j.lfs.2022.120986_bb0085","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1002\/jnr.21438","article-title":"Regulation of membrane association and kinase activity of Cdk5-p35 by phosphorylation of p35","volume":"85","author":"Sato","year":"2007","journal-title":"J. Neurosci. Res."},{"issue":"5","key":"10.1016\/j.lfs.2022.120986_bb0090","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/dgd.12138","article-title":"Cdk5 regulates multiple cellular events in development, function and disease","volume":"56","author":"Kawauchi","year":"2014","journal-title":"Develop. Growth Differ."},{"issue":"45","key":"10.1016\/j.lfs.2022.120986_bb0095","doi-asserted-by":"crossref","first-page":"15127","DOI":"10.1523\/JNEUROSCI.1443-15.2015","article-title":"Cdk5 regulates activity-dependent gene expression and dendrite development","volume":"35","author":"Liang","year":"2015","journal-title":"J. Neurosci."},{"issue":"39","key":"10.1016\/j.lfs.2022.120986_bb0100","doi-asserted-by":"crossref","first-page":"8954","DOI":"10.1523\/JNEUROSCI.2899-05.2005","article-title":"Differential roles of nuclear and cytoplasmic cyclin-dependent kinase 5 in apoptotic and excitotoxic neuronal death","volume":"25","author":"O'Hare","year":"2005","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.lfs.2022.120986_bb0105","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/j.1471-4159.2011.07222.x","article-title":"Calpastatin, an endogenous calpain-inhibitor protein, regulates the cleavage of the Cdk5 activator p35 to p25","volume":"117","author":"Sato","year":"2011","journal-title":"J. Neurochem."},{"issue":"10","key":"10.1016\/j.lfs.2022.120986_bb0110","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1172\/JCI37978","article-title":"Cyclin I activates Cdk5 and regulates expression of Bcl-2 and bcl-XL in postmitotic mouse cells","volume":"119","author":"Brinkkoetter","year":"2009","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.lfs.2022.120986_bb0115","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0896-6273(01)80044-1","article-title":"Mice lacking p35, a neuronal specific activator of Cdk5, display cortical lamination defects, seizures, and adult lethality","volume":"18","author":"Chae","year":"1997","journal-title":"Neuron"},{"issue":"20","key":"10.1016\/j.lfs.2022.120986_bb0120","doi-asserted-by":"crossref","first-page":"11173","DOI":"10.1073\/pnas.93.20.11173","article-title":"Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death","volume":"93","author":"Ohshima","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6","key":"10.1016\/j.lfs.2022.120986_bb0125","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1111\/j.1471-4159.2010.07050.x","article-title":"Regulation and role of cyclin-dependent kinase activity in neuronal survival and death","volume":"115","author":"Hisanaga","year":"2010","journal-title":"J. Neurochem."},{"issue":"17","key":"10.1016\/j.lfs.2022.120986_bb0130","doi-asserted-by":"crossref","first-page":"6758","DOI":"10.1523\/JNEUROSCI.21-17-06758.2001","article-title":"p35 and p39 are essential for cyclin dependent kinase 5 function during neurodevelopment","volume":"21","author":"Ko","year":"2001","journal-title":"J. Neurosci."},{"issue":"10","key":"10.1016\/j.lfs.2022.120986_bb0135","doi-asserted-by":"crossref","first-page":"8054","DOI":"10.1074\/jbc.M109645200","article-title":"Calpain-mediated cleavage of the cyclin-dependent kinase-5 activator p39 to p29","volume":"277","author":"Patzke","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"36","key":"10.1016\/j.lfs.2022.120986_bb0140","doi-asserted-by":"crossref","first-page":"31522","DOI":"10.1074\/jbc.M504792200","article-title":"Phosphorylation of FTDP-17 mutant tau by cyclin-dependent kinase 5 complexed with p35, p25, or p39","volume":"280","author":"Sakaue","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.lfs.2022.120986_bb0145","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1471-4159.2007.04540.x","article-title":"p25\/Cyclin-dependent kinase 5 promotes the progression of cell death in nucleus of endoplasmic reticulum-stressed neurons","volume":"102","author":"Saito","year":"2007","journal-title":"J. Neurochem."},{"issue":"5","key":"10.1016\/j.lfs.2022.120986_bb0150","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1111\/j.1471-4159.2007.04505.x","article-title":"Cdk5-p39 is a labile complex with the similar substrate specificity to Cdk5-p35","volume":"102","author":"Yamada","year":"2007","journal-title":"J. Neurochem."},{"issue":"4","key":"10.1016\/j.lfs.2022.120986_bb0155","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1523\/JNEUROSCI.23-04-01189.2003","article-title":"Developmental regulation of the proteolysis of the p35 cyclin-dependent kinase 5 activator by phosphorylation","volume":"23","author":"Saito","year":"2003","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.lfs.2022.120986_bb0160","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1074\/jbc.M610541200","article-title":"Suppression of calpain-dependent cleavage of the CDK5 activator p35 to p25 by site-specific phosphorylation","volume":"282","author":"Kamei","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"45","key":"10.1016\/j.lfs.2022.120986_bb0165","doi-asserted-by":"crossref","first-page":"26897","DOI":"10.1074\/jbc.270.45.26897","article-title":"An isoform of the neuronal cyclin-dependent kinase 5 (Cdk5) activator","volume":"270","author":"Tang","year":"1995","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.lfs.2022.120986_bb0170","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/(SICI)1097-4695(199805)35:2<141::AID-NEU2>3.0.CO;2-4","article-title":"Region-specific expression of cyclin-dependent kinase 5 (cdk5) and its activators, p35 and p39, in the developing and adult rat central nervous system","volume":"35","author":"Zheng","year":"1998","journal-title":"J. Neurobiol."},{"issue":"22","key":"10.1016\/j.lfs.2022.120986_bb0175","doi-asserted-by":"crossref","first-page":"21376","DOI":"10.1074\/jbc.M501215200","article-title":"A specific interaction between muskelin and the cyclin-dependent kinase 5 activator p39 promotes peripheral localization of muskelin","volume":"280","author":"Ledee","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"28","key":"10.1016\/j.lfs.2022.120986_bb0180","doi-asserted-by":"crossref","first-page":"19627","DOI":"10.1074\/jbc.M113.501148","article-title":"Phosphorylation of cyclin-dependent kinase5 (Cdk5) at Tyr-15 is inhibited by Cdk5 activators and does not contribute to the activation of Cdk5","volume":"289","author":"Kobayashi","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"26","key":"10.1016\/j.lfs.2022.120986_bb0185","doi-asserted-by":"crossref","first-page":"5482","DOI":"10.1021\/bi100631f","article-title":"Membrane association facilitates degradation and cleavage of the cyclin-dependent kinase 5 activators p35 and p39","volume":"49","author":"Minegishi","year":"2010","journal-title":"Biochemistry"},{"issue":"3","key":"10.1016\/j.lfs.2022.120986_bb0190","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1111\/j.1471-4159.2008.05500.x","article-title":"Myristoylation of p39 and p35 is a determinant of cytoplasmic or nuclear localization of active cycline-dependent kinase 5 (Cdk5) complexes","volume":"106","author":"Asada","year":"2008","journal-title":"J. Neurochem."},{"issue":"12","key":"10.1016\/j.lfs.2022.120986_bb0195","doi-asserted-by":"crossref","first-page":"10506","DOI":"10.1074\/jbc.M211964200","article-title":"Tau phosphorylation by cyclin-dependent kinase 5\/p39 during brain development reduces its affinity for microtubules","volume":"278","author":"Takahashi","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.lfs.2022.120986_bb0200","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0306-4522(03)00002-2","article-title":"The cyclin-dependent kinase 5 activator, p39, is expressed in stripes in the mouse cerebellum","volume":"118","author":"Jeong","year":"2003","journal-title":"Neuroscience"},{"issue":"6784","key":"10.1016\/j.lfs.2022.120986_bb0205","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/35012636","article-title":"Neurotoxicity induces cleavage of p35 to p25 by calpain","volume":"405","author":"Lee","year":"2000","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.lfs.2022.120986_bb0210","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.tins.2016.01.007","article-title":"Calpain-1 and calpain-2: the yin and yang of synaptic plasticity and neurodegeneration","volume":"39","author":"Baudry","year":"2016","journal-title":"Trends Neurosci."},{"issue":"3","key":"10.1016\/j.lfs.2022.120986_bb0215","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1042\/bj3280721","article-title":"Structure and physiological function of calpains","volume":"328","author":"Sorimachi","year":"1997","journal-title":"Biochem. J."},{"issue":"8","key":"10.1016\/j.lfs.2022.120986_bb0220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0042318","article-title":"Involvement of calpain\/p35-p25\/Cdk5\/NMDAR signalling pathway in glutamate-induced neurotoxicity in cultured rat retinal neurons","volume":"7","author":"Miao","year":"2012","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.lfs.2022.120986_bb0225","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1023\/A:1007544106645","article-title":"The expression of Cdk5, p35, p39, and Cdk5 kinase activity in developing, adult, and aged rat brains","volume":"25","author":"Wu","year":"2000","journal-title":"Neurochem. Res."},{"issue":"6","key":"10.1016\/j.lfs.2022.120986_bb0230","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1242\/jcs.113.6.975","article-title":"p39 activates cdk5 in neurons, and is associated with the actin cytoskeleton","volume":"113","author":"Humbert","year":"2000","journal-title":"J. Cell Sci."},{"issue":"47","key":"10.1016\/j.lfs.2022.120986_bb0235","doi-asserted-by":"crossref","first-page":"18567","DOI":"10.1073\/pnas.0810137105","article-title":"Cdk5 is essential for adult hippocampal neurogenesis","volume":"105","author":"Lagace","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.lfs.2022.120986_bb0240","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/(SICI)1097-4644(19980101)68:1<128::AID-JCB13>3.0.CO;2-D","article-title":"Changes in the activity of cdk2 and cdk5 accompany differentiation of rat primary oligodendrocytes","volume":"68","author":"Tang","year":"1998","journal-title":"J. Cell. Biochem."},{"issue":"24","key":"10.1016\/j.lfs.2022.120986_bb0245","doi-asserted-by":"crossref","first-page":"4355","DOI":"10.1242\/jcs.018218","article-title":"Cdk5 regulates differentiation of oligodendrocyte precursor cells through the direct phosphorylation of paxillin","volume":"120","author":"Miyamoto","year":"2007","journal-title":"J. Cell Sci."},{"issue":"33","key":"10.1016\/j.lfs.2022.120986_bb0250","doi-asserted-by":"crossref","first-page":"8326","DOI":"10.1523\/JNEUROSCI.1482-08.2008","article-title":"Cdk5 phosphorylation of WAVE2 regulates oligodendrocyte precursor cell migration through nonreceptor tyrosine kinase Fyn","volume":"28","author":"Miyamoto","year":"2008","journal-title":"J. Neurosci."},{"issue":"25","key":"10.1016\/j.lfs.2022.120986_bb0255","doi-asserted-by":"crossref","first-page":"18047","DOI":"10.1074\/jbc.M113.453688","article-title":"p39, the primary activator for cyclin-dependent kinase 5 (Cdk5) in oligodendroglia, is essential for oligodendroglia differentiation and myelin repair","volume":"288","author":"Bankston","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.lfs.2022.120986_bb0260","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0301-0082(02)00058-8","article-title":"Regulation of oligodendrocyte development in the vertebrate CNS","volume":"67","author":"Miller","year":"2002","journal-title":"Prog. Neurobiol."},{"issue":"7","key":"10.1016\/j.lfs.2022.120986_bb0265","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.tins.2008.04.001","article-title":"White matter in learning, cognition and psychiatric disorders","volume":"31","author":"Fields","year":"2008","journal-title":"Trends Neurosci."},{"issue":"3","key":"10.1016\/j.lfs.2022.120986_bb0270","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.bbadis.2011.07.009","article-title":"White matter integrity and vulnerability to Alzheimer\u2019s disease: preliminary findings and future directions","volume":"1822","author":"Gold","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"issue":"2","key":"10.1016\/j.lfs.2022.120986_bb0275","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s12264-013-1321-3","article-title":"Oligodendroglia and neurotrophic factors in neurodegeneration","volume":"29","author":"Bankston","year":"2013","journal-title":"Neurosci. Bull."},{"issue":"3","key":"10.1016\/j.lfs.2022.120986_bb0280","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1017\/S1461145712001095","article-title":"Improving myelin\/oligodendrocyte-related dysfunction; a new mechanism of antipsychotics in the treatment of schizophrenia?","volume":"16","author":"Ren","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"2","key":"10.1016\/j.lfs.2022.120986_bb0285","doi-asserted-by":"crossref","first-page":"345","DOI":"10.5114\/aoms.2018.76863","article-title":"The role of myelin damage in Alzheimer\u2019s disease pathology","volume":"16","author":"Papu\u0107","year":"2018","journal-title":"Arch. Med. Sci."},{"issue":"10","key":"10.1016\/j.lfs.2022.120986_bb0290","doi-asserted-by":"crossref","first-page":"5443","DOI":"10.1074\/jbc.271.10.5443","article-title":"Demonstration of cyclin-dependent kinase inhibitory serine\/threonine kinase in bovine thymus","volume":"271","author":"Matsuura","year":"1996","journal-title":"J. Biol. Chem."},{"issue":"20","key":"10.1016\/j.lfs.2022.120986_bb0295","doi-asserted-by":"crossref","first-page":"11156","DOI":"10.1073\/pnas.96.20.11156","article-title":"Regulation of cyclin-dependent kinase 5 catalytic activity by phosphorylation","volume":"96","author":"Sharma","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.lfs.2022.120986_bb0300","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0896-6273(00)81200-3","article-title":"Cables links Cdk5 and c-abl and facilitates Cdk5 tyrosine phosphorylation, kinase upregulation, and neurite outgrowth","volume":"26","author":"Zukerberg","year":"2000","journal-title":"Neuron"},{"issue":"5","key":"10.1016\/j.lfs.2022.120986_bb0305","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S0896-6273(02)00857-7","article-title":"Fyn and Cdk5 mediate semaphoring-3A signaling, which is involved in regulation of dendrite orientation in cerebral cortex","volume":"35","author":"Sasaki","year":"2002","journal-title":"Neuron"},{"issue":"14","key":"10.1016\/j.lfs.2022.120986_bb0310","first-page":"3421","article-title":"Phosphorylation of p35 and p39 by Cdk5 determines the subcellular location of the holokinase in a phosphorylation-site-specific manner","volume":"125","author":"Asada","year":"2012","journal-title":"J. Cell Sci."},{"issue":"51","key":"10.1016\/j.lfs.2022.120986_bb0315","doi-asserted-by":"crossref","first-page":"39014","DOI":"10.1074\/jbc.M512663200","article-title":"Identification of nuclear import mechanisms for the neuronal Cdk5 activator","volume":"281","author":"Fu","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"15","key":"10.1016\/j.lfs.2022.120986_bb0320","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1242\/dev.091744","article-title":"Cdks, cyclins and CKIs: roles beyond cell cycle regulation","volume":"140","author":"Lim","year":"2013","journal-title":"Development"},{"issue":"3","key":"10.1016\/j.lfs.2022.120986_bb0325","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s12035-012-8309-2","article-title":"Regulation of APC\/C-Cdh1 and its function in neuronal survival","volume":"46","author":"Almeida","year":"2012","journal-title":"Mol. Neurobiol."},{"issue":"36","key":"10.1016\/j.lfs.2022.120986_bb0330","doi-asserted-by":"crossref","first-page":"8115","DOI":"10.1523\/JNEUROSCI.1143-05.2005","article-title":"Cdh1\/Hct1-APC is essential for the survival of postmitotic neurons","volume":"25","author":"Almeida","year":"2005","journal-title":"J. Neurosci."},{"issue":"15","key":"10.1016\/j.lfs.2022.120986_bb0335","doi-asserted-by":"crossref","first-page":"5219","DOI":"10.1523\/JNEUROSCI.5628-09.2010","article-title":"Cdk5 suppresses the neuronal cell cycle by disrupting the E2F1\u2013DP1 complex","volume":"30","author":"Zhang","year":"2010","journal-title":"J. Neurosci."},{"issue":"8","key":"10.1016\/j.lfs.2022.120986_bb0340","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.4161\/cc.20009","article-title":"Cyclin-dependent kinase 5 regulates E2F transcription factor through phosphorylation of rb protein in neurons","volume":"11","author":"Futatsugi","year":"2012","journal-title":"Cell Cycle"},{"issue":"4","key":"10.1016\/j.lfs.2022.120986_bb0345","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.devcel.2011.08.009","article-title":"Cyclin E constrains Cdk5 activity to regulate synaptic plasticity and memory formation","volume":"21","author":"Odajima","year":"2011","journal-title":"Dev. Cell"},{"issue":"42","key":"10.1016\/j.lfs.2022.120986_bb0350","doi-asserted-by":"crossref","first-page":"9658","DOI":"10.1523\/JNEUROSCI.1773-05.2005","article-title":"Cyclin-dependent kinase 5 is essential for neuronal cell cycle arrest and differentiation","volume":"25","author":"Cicero","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.lfs.2022.120986_bb0355","doi-asserted-by":"crossref","first-page":"18180","DOI":"10.1038\/srep18180","article-title":"Cdk5-mediated inhibition of APC\/C-Cdh1 switches on the cyclin D1-Cdk4-pRb pathway causing aberrant S-phase entry of postmitotic neurons","volume":"5","author":"Veas-P\u00e9rez de Tudela","year":"2015","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.lfs.2022.120986_bb0360","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1471-4159.2008.05616.x","article-title":"Deregulated Cdk5 promotes oxidative stress and mitochondrial dysfunction","volume":"107","author":"Sun","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.lfs.2022.120986_bb0365","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3389\/fncel.2020.00235","article-title":"Streptozotocin induces Alzheimer\u2019s disease-like pathology in hippocampal neuronal cells via CDK5\/Drp1-mediated mitochondrial fragmentation","volume":"14","author":"Park","year":"2020","journal-title":"Front. Cell. Neurosci."},{"issue":"9","key":"10.1016\/j.lfs.2022.120986_bb0370","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1091\/mbc.e10-07-0654","article-title":"Nuclear envelope dispersion triggered by deregulated Cdk5 precedes neuronal death","volume":"22","author":"Chang","year":"2011","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.lfs.2022.120986_bb0375","article-title":"The role of NLRP3 inflammasome in Alzheimer's disease and potential therapeutic targets","volume":"13","author":"Liang","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"11","key":"10.1016\/j.lfs.2022.120986_bb0380","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1007\/s00221-020-05916-6","article-title":"Protection of MCC950 against Alzheimer\u2019s disease via inhibiting neuronal pyroptosis in SAMP8 mice","volume":"238","author":"Li","year":"2020","journal-title":"Exp. Brain Res."},{"issue":"3","key":"10.1016\/j.lfs.2022.120986_bb0385","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.bbrc.2019.11.141","article-title":"The BRCC3 regulated by Cdk5 promotes the activation of neuronal NLRP3 inflammasome in Parkinson's disease models","volume":"522","author":"Cheng","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.lfs.2022.120986_bb0390","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.molcel.2012.11.009","article-title":"Deubiquitination of NLRP3 by BRCC3 critically regulates inflammasome activity","volume":"49","author":"Py","year":"2013","journal-title":"Mol. Cell"},{"key":"10.1016\/j.lfs.2022.120986_bb0395","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2020.135279","article-title":"Beta-amyloid activates NLRP3 inflammasome via TLR4 in mouse microglia","volume":"736","author":"Liu","year":"2020","journal-title":"Neurosci. Lett."},{"issue":"4","key":"10.1016\/j.lfs.2022.120986_bb0400","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1074\/jbc.M805052200","article-title":"Tumor necrosis factor-alpha regulates cyclin-dependent kinase 5 activity during pain signalling through transcriptional activation of p35","volume":"284","author":"Utreras","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.lfs.2022.120986_bb0405","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1002\/eji.201041266","article-title":"Role of CLIC4 in the host innate responses to bacterial lipopolysaccharide","volume":"41","author":"He","year":"2011","journal-title":"Eur. J. Immunol."},{"issue":"10","key":"10.1016\/j.lfs.2022.120986_bb0410","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1038\/s41419-018-0983-1","article-title":"Cyclin-dependent kinase 5-mediated phosphorylation of chloride intracellular channel 4 promotes oxidative stress-induced neuronal death","volume":"9","author":"Guo","year":"2018","journal-title":"Cell Death Dis."},{"issue":"29","key":"10.1016\/j.lfs.2022.120986_bb0415","doi-asserted-by":"crossref","first-page":"12077","DOI":"10.1074\/jbc.M117.797126","article-title":"The intracellular chloride channel proteins CLIC1 and CLIC4 induce IL-1\u03b2 transcription and activate the NLRP3 inflammasome","volume":"292","author":"Domingo-Fern\u00e1ndez","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2022.120986_bb0420","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.neuint.2016.01.005","article-title":"The mechanisms regulating cyclin-dependent kinase 5 in hippocampus during systemic inflammatory response: the effect on inflammatory gene expression","volume":"93","author":"Czapski","year":"2016","journal-title":"Neurochem. Int."},{"issue":"1","key":"10.1016\/j.lfs.2022.120986_bb0425","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-017-1027-y","article-title":"Inhibition of cyclin-dependent kinase 5 affects early neuroinflammatory signalling in murine model of amyloid beta toxicity","volume":"15","author":"Wilkaniec","year":"2018","journal-title":"J. Neuroinflammation"},{"issue":"2","key":"10.1016\/j.lfs.2022.120986_bb0430","doi-asserted-by":"crossref","first-page":"470","DOI":"10.2353\/ajpath.2008.070693","article-title":"Neurodegeneration and neuroinflammation in cdk5\/p25-inducible mice","volume":"172","author":"Muyllaert","year":"2008","journal-title":"Am. J. Pathol."},{"issue":"3","key":"10.1016\/j.lfs.2022.120986_bb0435","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1523\/JNEUROSCI.5177-11.2012","article-title":"Cdk5\/p25-induced cytosolic PLA2-mediated lysophosphatidylcholine production regulates neuroinflammation and triggers neurodegeneration","volume":"32","author":"Sundaram","year":"2012","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.lfs.2022.120986_bb0440","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1083\/jcb.143.2.457","article-title":"Cyclin-dependent kinases participate in death of neurons evoked by DNA-damaging agents","volume":"143","author":"Park","year":"1998","journal-title":"J. Cell Biol."},{"issue":"14","key":"10.1016\/j.lfs.2022.120986_bb0445","doi-asserted-by":"crossref","first-page":"5017","DOI":"10.1523\/JNEUROSCI.21-14-05017.2001","article-title":"Cyclin-dependent kinases and P53 pathways are activated independently and mediate bax activation in neurons after DNA damage","volume":"21","author":"Morris","year":"2001","journal-title":"J. Neurosci."},{"issue":"38","key":"10.1016\/j.lfs.2022.120986_bb0450","doi-asserted-by":"crossref","first-page":"35586","DOI":"10.1074\/jbc.M204362200","article-title":"Interaction of the c-Jun\/JNK pathway and cyclin-dependent kinases in death of embryonic cortical neurons evoked by DNA damage","volume":"277","author":"Ghahremani","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"18","key":"10.1016\/j.lfs.2022.120986_bb0455","doi-asserted-by":"crossref","first-page":"3722","DOI":"10.1091\/mbc.e12-02-0125","article-title":"Interplay between MEK-ERK signaling, cyclin D1, and cyclin-dependent kinase 5 regulates cell cycle reentry and apoptosis of neurons","volume":"23","author":"Modi","year":"2012","journal-title":"Mol. Biol. Cell"},{"issue":"20","key":"10.1016\/j.lfs.2022.120986_bb0460","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1038\/emboj.2008.195","article-title":"Cdk5 phosphorylates Cdh1 and modulates cyclin B1 stability in excitotoxicity","volume":"27","author":"Maestre","year":"2008","journal-title":"EMBO J."},{"issue":"8","key":"10.1016\/j.lfs.2022.120986_bb0465","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1523\/JNEUROSCI.21-08-02661.2001","article-title":"DNA replication precedes neuronal cell death in Alzheimer's disease","volume":"21","author":"Yang","year":"2001","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.lfs.2022.120986_bb0470","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.neulet.2007.03.026","article-title":"p53 is upregulated in Alzheimer's disease and induces tau phosphorylation in HEK293a cells","volume":"418","author":"Hooper","year":"2007","journal-title":"Neurosci. Lett."},{"issue":"2","key":"10.1016\/j.lfs.2022.120986_bb0475","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.neulet.2012.03.093","article-title":"Combination of p53(ser15) and p21\/p21(thr145) in peripheral blood lymphocytes as potential Alzheimer's disease biomarkers","volume":"516","author":"Tan","year":"2012","journal-title":"Neurosci. Lett."},{"issue":"6","key":"10.1016\/j.lfs.2022.120986_bb0480","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/sj.mp.4002060","article-title":"Conformationally altered p53: a novel Alzheimer's disease marker?","volume":"13","author":"Lanni","year":"2008","journal-title":"Mol. Psychiatry"},{"issue":"3","key":"10.1016\/j.lfs.2022.120986_bb0485","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.neulet.2009.11.024","article-title":"P53-mediated G(1)\/S checkpoint dysfunction in lymphocytes from Alzheimer\u2019s disease patients","volume":"468","author":"Zhou","year":"2010","journal-title":"Neurosci. Lett."},{"issue":"50","key":"10.1016\/j.lfs.2022.120986_bb0490","doi-asserted-by":"crossref","first-page":"18055","DOI":"10.1073\/pnas.1419083111","article-title":"p53 prevents neurodegeneration by regulating synaptic genes","volume":"111","author":"Merlo","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lfs.2022.120986_bb0495","doi-asserted-by":"crossref","first-page":"7969272","DOI":"10.1155\/2016\/7969272","article-title":"Emerging link between Alzheimer's disease and homeostatic synaptic plasticity","volume":"2016","author":"Jang","year":"2016","journal-title":"Neural Plast."},{"issue":"28","key":"10.1016\/j.lfs.2022.120986_bb0500","doi-asserted-by":"crossref","first-page":"19826","DOI":"10.1074\/jbc.M706201200","article-title":"Cooperative roles of c-abl and Cdk5 in regulation of p53 in response to oxidative stress","volume":"283","author":"Lee","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2022.120986_bb0505","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.neuropharm.2018.11.019","article-title":"Amyloid-\u03b2 promotes neurotoxicity by Cdk5-induced p53 stabilization","volume":"146","author":"Lapresa","year":"2019","journal-title":"Neuropharmacology"},{"issue":"13","key":"10.1016\/j.lfs.2022.120986_bb0510","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1242\/jcs.03468","article-title":"Stabilization and activation of p53 induced by Cdk5 contributes to neuronal cell death","volume":"120","author":"Lee","year":"2007","journal-title":"J. Cell Sci."},{"issue":"1","key":"10.1016\/j.lfs.2022.120986_bb0515","doi-asserted-by":"crossref","first-page":"13032","DOI":"10.1038\/s41598-019-49623-x","article-title":"Down-regulation of cyclin-dependent kinase 5 attenuates p53-dependent apoptosis of hippocampal CA1 pyramidal neurons following transient cerebral ischemia","volume":"9","author":"Shin","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2022.120986_bb0520","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1007\/s11055-016-0342-6","article-title":"The role of p53 protein in the regulation of neuronal differentiation","volume":"46","author":"Glazova","year":"2016","journal-title":"Neurosci. Behav. Phys."},{"issue":"1","key":"10.1016\/j.lfs.2022.120986_bb0525","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/sj.cdd.4401717","article-title":"p53, Apaf-1, caspase-3, and -9 are dispensable for Cdk5 activation during cell death","volume":"13","author":"Lin","year":"2006","journal-title":"Cell Death Differ."},{"issue":"1","key":"10.1016\/j.lfs.2022.120986_bb0530","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1128\/MCB.17.1.460","article-title":"Proteolytic cleavage of human p53 by calpain: a potential regulator of protein stability","volume":"17","author":"Kubbutat","year":"1997","journal-title":"Mol. Cell. Biol."},{"issue":"28","key":"10.1016\/j.lfs.2022.120986_bb0535","doi-asserted-by":"crossref","first-page":"26031","DOI":"10.1074\/jbc.M302833200","article-title":"Calpains mediate p53 activation and neuronal death evoked by DNA damage","volume":"278","author":"Sedarous","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.lfs.2022.120986_bb0540","doi-asserted-by":"crossref","first-page":"13119","DOI":"10.1038\/s41598-018-31073-6","article-title":"Isoform-specific hyperactivation of calpain-2 occurs presymptomatically at the synapse in Alzheimer's disease mice and correlates with memory deficits in human subjects","volume":"8","author":"Ahmad","year":"2018","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.lfs.2022.120986_bb0545","doi-asserted-by":"crossref","first-page":"3610","DOI":"10.1128\/MCB.22.11.3610-3620.2002","article-title":"mtCLIC\/CLIC4, an organellular chloride channel protein, is increased by DNA damage and participates in the apoptotic response to p53","volume":"22","author":"Fern\u00e1ndez-Salas","year":"2002","journal-title":"Mol. Cell. Biol."},{"issue":"1","key":"10.1016\/j.lfs.2022.120986_bb0550","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1365-2133.2005.06583.x","article-title":"CDK5 regulates cell-cell and cell-matrix adhesion in human keratinocytes","volume":"153","author":"Nakano","year":"2005","journal-title":"Br. J. Dermatol."},{"issue":"4","key":"10.1016\/j.lfs.2022.120986_bb0555","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S1474-4422(04)00707-0","article-title":"Alzheimer\u2019s disease: the two-hit hypothesis","volume":"3","author":"Zhu","year":"2004","journal-title":"Lancet Neurol."},{"issue":"4","key":"10.1016\/j.lfs.2022.120986_bb0560","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.bbadis.2006.10.014","article-title":"Alzheimer disease, the two-hit hypothesis: an update","volume":"1772","author":"Zhu","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"issue":"2","key":"10.1016\/j.lfs.2022.120986_bb0565","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1128\/MCB.24.2.865-874.2004","article-title":"Transcriptional regulation of BACE1, the beta-amyloid precursor protein beta-secretase, by Sp1","volume":"24","author":"Christensen","year":"2004","journal-title":"Mol. Cell. Biol."},{"issue":"9","key":"10.1016\/j.lfs.2022.120986_bb0570","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0007035","article-title":"Overexpression of transcription factor Sp1 leads to gene expression perturbations and cell cycle inhibition","volume":"4","author":"Deniaud","year":"2009","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.lfs.2022.120986_bb0575","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1002\/jnr.21695","article-title":"Transcription factor Sp1 dysregulation in Alzheimer's disease","volume":"86","author":"Citron","year":"2008","journal-title":"J. Neurosci. Res."},{"issue":"5","key":"10.1016\/j.lfs.2022.120986_bb0580","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.neuron.2008.02.024","article-title":"Transcriptional regulation of beta-secretase by p25\/cdk5 leads to enhanced amyloidogenic processing","volume":"57","author":"Wen","year":"2008","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.lfs.2022.120986_bb0585","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1046\/j.1471-4159.2000.0751085.x","article-title":"Neuron-specific phosphorylation of Alzheimer\u2019s beta-amyloid precursor protein by cyclin-dependent kinase 5","volume":"75","author":"Iijima","year":"2000","journal-title":"J. Neurochem."},{"issue":"3","key":"10.1016\/j.lfs.2022.120986_bb0590","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0896-6273(03)00627-5","article-title":"Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles","volume":"40","author":"Cruz","year":"2003","journal-title":"Neuron"},{"issue":"8","key":"10.1016\/j.lfs.2022.120986_bb0595","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0136950","article-title":"Enhancement of BACE1 activity by p25\/Cdk5-mediated phosphorylation in Alzheimer's disease","volume":"10","author":"Song","year":"2015","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.lfs.2022.120986_bb0600","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.cell.2010.06.036","article-title":"Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models","volume":"142","author":"Ittner","year":"2010","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.lfs.2022.120986_bb0605","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nrn2967","article-title":"Amyloid-\u03b2 and tau \u2013 a toxic pas de deux in Alzheimer's disease","volume":"12","author":"Ittner","year":"2011","journal-title":"Nat. Rev. Neurosci."},{"issue":"3","key":"10.1016\/j.lfs.2022.120986_bb0610","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1212\/01.WNL.0000106953.49802.9C","article-title":"Platelet APP, ADAM 10 and BACE alterations in the early stages of Alzheimer\u2019s disease","volume":"62","author":"Colciaghi","year":"2004","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.lfs.2022.120986_bb0615","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2174\/1567205015666181109103742","article-title":"Alterations in the expression of amyloid precursor protein cleaving enzymes mRNA in Alzheimer peripheral blood","volume":"16","author":"Wongchitrat","year":"2019","journal-title":"Curr. Alz. Res."},{"key":"10.1016\/j.lfs.2022.120986_bb0620","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1750-1326-1-5","article-title":"The amyloid precursor protein: beyond amyloid","volume":"1","author":"Zheng","year":"2006","journal-title":"Mol. Neurodegener."},{"issue":"11","key":"10.1016\/j.lfs.2022.120986_bb0625","doi-asserted-by":"crossref","first-page":"4327","DOI":"10.1128\/MCB.02393-05","article-title":"Phosphorylation of amyloid precursor protein (APP) at Thr668 regulates the nuclear translocation of the APP intracellular domain and induces neurodegeneration","volume":"26","author":"Chang","year":"2006","journal-title":"Mol. Cell. Biol."},{"issue":"1","key":"10.1016\/j.lfs.2022.120986_bb0630","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1083\/jcb.200301115","article-title":"APP processing is regulated by cytoplasmic phosphorylation","volume":"163","author":"Lee","year":"2003","journal-title":"J. Cell Biol."},{"issue":"6","key":"10.1016\/j.lfs.2022.120986_bb0635","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s00401-007-0211-z","article-title":"Amyloid precursor protein cytoplasmic domain with phosphor-Thr668 accumulates in Alzheimer\u2019s disease and its transgenic models: a role to mediate interaction of abeta and tau","volume":"113","author":"Shin","year":"2007","journal-title":"Acta Neuropathol."},{"issue":"1","key":"10.1016\/j.lfs.2022.120986_bb0640","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S1074-5521(00)00063-6","article-title":"Inhibition of cyclin-dependent kinases, GSK-3beta and CK1 by hymenialdisine, a marine sponge constituent","volume":"7","author":"Meijer","year":"2000","journal-title":"Chem. Biol."},{"issue":"3","key":"10.1016\/j.lfs.2022.120986_bb0645","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S1097-2765(01)00343-4","article-title":"Structure and regulation of the CDK5-p25nck5a complex","volume":"8","author":"Tarricone","year":"2001","journal-title":"Mol. Cell"},{"issue":"2","key":"10.1016\/j.lfs.2022.120986_bb0650","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.ajpath.2012.04.020","article-title":"Calpain inhibitor A-705253 mitigates Alzheimer\u2019s disease-like pathology and cognitive decline in aged 3xTgAD mice","volume":"181","author":"Medeiros","year":"2012","journal-title":"Am. J. Pathol."},{"issue":"4","key":"10.1016\/j.lfs.2022.120986_bb0655","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.neuropharm.2012.05.011","article-title":"The novel calpain inhibitor A-705253 prevents stress-induced tau hyperphosphorylation in vitro and in vivo","volume":"63","author":"Nikkel","year":"2012","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.lfs.2022.120986_bb0660","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/acel.12185","article-title":"Modulation of p25 and inflammatory pathways by fisetin maintains cognitive function in Alzheimer\u2019s disease transgenic mice","volume":"13","author":"Currais","year":"2014","journal-title":"Aging Cell"},{"issue":"28","key":"10.1016\/j.lfs.2022.120986_bb0665","doi-asserted-by":"crossref","first-page":"9222","DOI":"10.1523\/JNEUROSCI.1132-14.2014","article-title":"Specific calpain inhibition by calpastatin prevents tauopathy and neurodegeneration and restores normal lifespan in tau P301L mice","volume":"34","author":"Rao","year":"2014","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.lfs.2022.120986_bb0670","doi-asserted-by":"crossref","first-page":"18437","DOI":"10.1038\/s41598-019-54971-9","article-title":"Brain targeting of 9c,11t-conjugated linoleic acid, a natural calpain inhibitor, preserves memory and reduces A\u03b2 and p25 accumulation in 5XFAD mice","volume":"9","author":"Binyamin","year":"2019","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.lfs.2022.120986_bb0675","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3390\/pharmaceutics12030284","article-title":"A novel NMDA receptor antagonist protects against cognitive decline presented by senescent mice","volume":"12","author":"Companys-Alemany","year":"2020","journal-title":"Pharmaceutics"},{"issue":"18","key":"10.1016\/j.lfs.2022.120986_bb0680","doi-asserted-by":"crossref","first-page":"4427","DOI":"10.1046\/j.1432-1033.2002.03133.x","article-title":"A peptide derived from cyclin-dependent kinase activator (p35) specifically inhibits Cdk5 activity and phosphorylation of tau protein in transfected cells","volume":"269","author":"Zheng","year":"2002","journal-title":"Eur. J. Biochem."},{"issue":"1","key":"10.1016\/j.lfs.2022.120986_bb0685","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/sj.emboj.7600441","article-title":"A Cdk5 inhibitory peptide reduces tau hyperphosphorylation and apoptosis in neurons","volume":"24","author":"Zheng","year":"2005","journal-title":"EMBO J."},{"issue":"1","key":"10.1016\/j.lfs.2022.120986_bb0690","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1523\/JNEUROSCI.3593-12.2013","article-title":"Specific inhibition of p25\/Cdk5 activity by the Cdk5 inhibitory peptide reduces neurodegeneration in vivo","volume":"33","author":"Sundaram","year":"2013","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.lfs.2022.120986_bb0695","doi-asserted-by":"crossref","first-page":"573","DOI":"10.3233\/JAD-190099","article-title":"AAV9-mediated Cdk5 inhibitory peptide reduces hyperphosphorylated tau and inflammation and ameliorates behavioral changes caused by overexpression of p25 in the brain","volume":"70","author":"Xu","year":"2019","journal-title":"J. Alzheimers Dis."},{"issue":"4","key":"10.1016\/j.lfs.2022.120986_bb0700","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.3233\/JAD-191098","article-title":"Cdk5 inhibitory peptide prevents loss of neurons and alleviates behavioral changes in p25 transgenic mice","volume":"74","author":"Huang","year":"2020","journal-title":"J. Alzheimers Dis."},{"issue":"44","key":"10.1016\/j.lfs.2022.120986_bb0705","doi-asserted-by":"crossref","first-page":"34202","DOI":"10.1074\/jbc.M110.134643","article-title":"A 24-residue peptide (p5), derived from p35, the Cdk5 neuronal activator, specifically inhibits Cdk5-p25 hyperactivity and tau hyperphosphorylation","volume":"285","author":"Zheng","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.lfs.2022.120986_bb0710","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1096\/fj.12-217497","article-title":"A truncated peptide from p35, a Cdk5 activator, prevents Alzheimer's disease phenotypes in model mice","volume":"27","author":"Shukla","year":"2013","journal-title":"FASEB J."},{"issue":"2","key":"10.1016\/j.lfs.2022.120986_bb0715","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.yexcr.2014.04.014","article-title":"High glucose increases Cdk5 activity in podocytes via transforming growth factor-b1 signaling pathway","volume":"326","author":"Zhang","year":"2014","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.lfs.2022.120986_bb0720","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.neuroscience.2016.12.009","article-title":"TFP5 is comparable to mild hypothermia in improving neurological outcomes in early-stage ischemic stroke of adult rats","volume":"343","author":"Ji","year":"2016","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.lfs.2022.120986_bb0725","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3233\/JAD-160916","article-title":"TFP5, a peptide inhibitor of aberrant and hyperactive Cdk5\/p25, attenuates pathological phenotypes and restores synaptic function in CK-p25Tg mice","volume":"56","author":"Shukla","year":"2017","journal-title":"J. Alzheimers Dis."},{"issue":"4","key":"10.1016\/j.lfs.2022.120986_bb0730","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.chembiol.2015.03.009","article-title":"Tamoxifen inhibits CDK5 kinase activity by interacting with p35\/p25 and modulates the pattern of tau phosphorylation","volume":"22","author":"Corbel","year":"2015","journal-title":"Chem. Biol."},{"key":"10.1016\/j.lfs.2022.120986_bb0735","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.yhbeh.2015.09.004","article-title":"Memory enhancement by tamoxifen on amyloidosis mouse model","volume":"79","author":"Pandey","year":"2016","journal-title":"Horm. Behav."},{"issue":"2","key":"10.1016\/j.lfs.2022.120986_bb0740","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.neuint.2012.04.019","article-title":"The protective effects of tanshinone IIA on neurotoxicity induced by \u03b2-amyloid protein through calpain and the p35\/Cdk5 pathway in primary cortical neurons","volume":"61","author":"Shi","year":"2012","journal-title":"Neurochem. Int."},{"issue":"50","key":"10.1016\/j.lfs.2022.120986_bb0745","doi-asserted-by":"crossref","first-page":"11542","DOI":"10.1523\/JNEUROSCI.3831-05.2005","article-title":"Suppression of cyclin-dependent kinase 5 activation by amyloid precursor protein: a novel excitoprotective mechanism involving modulation of tau phosphorylation","volume":"25","author":"Han","year":"2005","journal-title":"J. Neurosci."},{"issue":"6","key":"10.1016\/j.lfs.2022.120986_bb0750","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0065920","article-title":"Soluble alpha-APP (sAPPalpha) regulates CDK5 expression and activity in neurons","volume":"8","author":"Hartl","year":"2013","journal-title":"PLoS One"},{"issue":"18","key":"10.1016\/j.lfs.2022.120986_bb0755","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1080\/10408398.2018.1481012","article-title":"Neuro-nutrients as anti-Alzheimer\u2019s disease agents: a critical review","volume":"59","author":"Ravi","year":"2019","journal-title":"Crit. Rev. Food Sci. Nutr."},{"issue":"2","key":"10.1016\/j.lfs.2022.120986_bb0760","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/jpi.12200","article-title":"Melatonin stimulates the non amyloidogenic processing of \u03b2APP through the positive transcriptional regulation of ADAM10 and ADAM17","volume":"58","author":"Shukla","year":"2015","journal-title":"J. Pineal Res."},{"issue":"1","key":"10.1016\/j.lfs.2022.120986_bb0765","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1074\/jbc.M002466200","article-title":"Indirubins inhibit glycogen synthase kinase-3 beta and CDK5\/p25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer\u2019s disease. A property common to most cyclin-dependent kinase inhibitors?","volume":"276","author":"Leclerc","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.lfs.2022.120986_bb0770","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.bbrc.2004.03.019","article-title":"Specific inhibition of cyclin-dependent kineses and cell proliferation by harmine","volume":"317","author":"Song","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"7","key":"10.1016\/j.lfs.2022.120986_bb0775","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.chembiol.2005.05.011","article-title":"Defining Cdk5 ligand chemical space with small molecule inhibitors of tau phosphorylation","volume":"12","author":"Ahn","year":"2005","journal-title":"Chem. Biol."},{"issue":"4","key":"10.1016\/j.lfs.2022.120986_bb0780","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1021\/np070341r","article-title":"Butyrolactone I derivatives from aspergillus terreus carrying an unusual sulphate moiety","volume":"71","author":"Niu","year":"2008","journal-title":"J. Nat. Prod."},{"issue":"13","key":"10.1016\/j.lfs.2022.120986_bb0785","doi-asserted-by":"crossref","first-page":"4420","DOI":"10.1016\/j.bmc.2009.05.017","article-title":"Synthesis and biological activities of aminopyrimidyl-indoles structurally relates to meridianins","volume":"17","author":"Akue-Gedu","year":"2009","journal-title":"Bioorg. Med. Chem."},{"issue":"6","key":"10.1016\/j.lfs.2022.120986_bb0790","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1007\/BF03253192","article-title":"Constituents of Machilus thunbergii Bark and inhibition of cycli-dependent kinases (CDKs) by procyanidin B2","volume":"54","author":"Shrestha","year":"2011","journal-title":"J. Korean Sco. Appl. Biol. Chem."},{"issue":"9","key":"10.1016\/j.lfs.2022.120986_bb0795","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1002\/rcm.6537","article-title":"Determination of kinetic parameters and structure-activity relationships of ginsenosides as inhibitors of cyclin-dependent kinase 5\/p25 using ultra-pressure liquid chromatography with triple quadrupole tandem mass spectrometry","volume":"27","author":"Chen","year":"2013","journal-title":"Rapid Commun. Mass Spectrom."},{"issue":"18","key":"10.1016\/j.lfs.2022.120986_bb0800","doi-asserted-by":"crossref","first-page":"5150","DOI":"10.1016\/j.bmcl.2013.07.020","article-title":"Potential neuroprotective flavonoid-based inhibitors of CDK5\/p25 from Rhus parviflora","volume":"23","author":"Shrestha","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"19","key":"10.1016\/j.lfs.2022.120986_bb0805","doi-asserted-by":"crossref","first-page":"5983","DOI":"10.1046\/j.1432-1327.2000.01673.x","article-title":"Paullones are potent inhibitors of glycogen synthase kinase-3beta and cyclin-dependent kinase 5\/p25","volume":"267","author":"Leost","year":"2000","journal-title":"Eur. J. Biochem."},{"issue":"7","key":"10.1016\/j.lfs.2022.120986_bb0810","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1016\/S0968-0896(02)00069-X","article-title":"Pyrazolo[3,4-b]quinoxalines. A new class of cyclin-dependent kinases inhibitors","volume":"10","author":"Ortega","year":"2002","journal-title":"Bioorg. Med. Chem."},{"issue":"2","key":"10.1016\/j.lfs.2022.120986_bb0815","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1021\/jm020319p","article-title":"Aloisines, a new family of CDK\/GSK-3 inhibitors. SAR study, crystal structure in complex with CDK2, enzyme selectivity, and cellular effects","volume":"46","author":"Mettey","year":"2003","journal-title":"J. Med. Chem."},{"issue":"22","key":"10.1016\/j.lfs.2022.120986_bb0820","doi-asserted-by":"crossref","first-page":"5521","DOI":"10.1016\/j.bmcl.2004.09.006","article-title":"Discovery and SAR of 2-aminothiazole inhibitors of cyclin-dependent linase 5\/p25 as a potential treatment of Alzheimer's disease","volume":"14","author":"Helal","year":"2004","journal-title":"Bioorg. Chem. Med. Lett."},{"issue":"3","key":"10.1016\/j.lfs.2022.120986_bb0825","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.ejmech.2005.12.004","article-title":"Synthesis of 3-substituted-2-oxoindole analogues and their evaluation as kinase inhibitors, anticancer and antiangiogenic agents","volume":"41","author":"Abadi","year":"2006","journal-title":"Eur. J. Med. Chem."},{"issue":"7","key":"10.1016\/j.lfs.2022.120986_bb0830","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1016\/j.bmc.2007.01.043","article-title":"Clubbed thiazoles by MAOS. A novel approach to cyclin-dependent kinase 5\/p25 inhibitors as a potential treatment for Alzheimer\u2019s disease","volume":"15","author":"Shiradkar","year":"2007","journal-title":"Bioorg. Med. Chem."},{"issue":"19","key":"10.1016\/j.lfs.2022.120986_bb0835","doi-asserted-by":"crossref","first-page":"6397","DOI":"10.1016\/j.bmc.2007.06.053","article-title":"A novel approach to cyclin-dependent kinase 5\/p25 inhibitors: a potential treatment for Alzheimer\u2019s disease","volume":"15","author":"Shiradkar","year":"2007","journal-title":"Bioorg. Med. Chem."},{"issue":"19","key":"10.1016\/j.lfs.2022.120986_bb0840","doi-asserted-by":"crossref","first-page":"5703","DOI":"10.1016\/j.bmcl.2009.08.019","article-title":"Potent and cellularly active 4-aminoimidazole inhibitors of cyclin-dependent kinase 5\/p25 for the treatment of Alzheimer\u2019s disease","volume":"19","author":"Helal","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"1","key":"10.1016\/j.lfs.2022.120986_bb0845","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.bmc.2010.11.022","article-title":"Design, synthesis, and testing of an 6-O-linked series of benzimidazole based inhibitors of CDK5\/p25","volume":"19","author":"Jain","year":"2011","journal-title":"Bioorg. Med. Chem."},{"issue":"17","key":"10.1016\/j.lfs.2022.120986_bb0850","doi-asserted-by":"crossref","first-page":"5229","DOI":"10.1021\/jm800109e","article-title":"Roscovitine-derived, dual-specificity inhibitors of cyclin-dependent kinases and casein kinase 1","volume":"51","author":"Oumata","year":"2008","journal-title":"J. Med. Chem."},{"issue":"7","key":"10.1016\/j.lfs.2022.120986_bb0855","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1016\/j.bmcl.2011.01.140","article-title":"Structure-activity relationship study of 2,4-diaminothiazoles as Cdk5\/p25 inhibitors","volume":"21","author":"Laha","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"18","key":"10.1016\/j.lfs.2022.120986_bb0860","doi-asserted-by":"crossref","first-page":"5919","DOI":"10.1016\/j.bmcl.2012.07.068","article-title":"Synthesis and structure \u2013activity relationship of 4-(1,3-benzothiazol-2-yl)-thiophene-2-sulfonamides as cyclin-dependent kinase 5 (cdk5)\/p25 inhibitors","volume":"22","author":"Malmstr\u00f6m","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"22","key":"10.1016\/j.lfs.2022.120986_bb0865","doi-asserted-by":"crossref","first-page":"6914","DOI":"10.1016\/j.bmcl.2012.09.006","article-title":"Multitargeted drug development: discovery and profiling of dihydroxy substituted 1-aza-9-oxafluorenes as lead compounds targeting alzheimer disease relevant kinases","volume":"22","author":"Tell","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"22","key":"10.1016\/j.lfs.2022.120986_bb0870","doi-asserted-by":"crossref","first-page":"6409","DOI":"10.1016\/j.bmc.2014.09.043","article-title":"Discovery of thienoquilonone derivatives as selective and ATP non-competitive CDK5\/p25 inhibitors by structure-based virtual screening","volume":"22","author":"Chatterjee","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.lfs.2022.120986_bb0875","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.ejmech.2016.08.069","article-title":"Further inverstigation of paprotrain: towards the conception of selective and multi-targeted CNS kinase inhibitors","volume":"124","author":"Labri\u00e8re","year":"2016","journal-title":"Eur. J. Med. Chem."},{"issue":"5","key":"10.1016\/j.lfs.2022.120986_bb0880","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3390\/ph13050089","article-title":"Exploring kinase inhibition properties of 9 H-pyrimido[5,4-b]- and [4,5-b]indol-4-amine derivatives","volume":"13","author":"Loidreau","year":"2020","journal-title":"Pharmaceuticals (Basel)"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320522006865?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320522006865?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T21:11:12Z","timestamp":1758402672000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320522006865"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":176,"alternative-id":["S0024320522006865"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2022.120986","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cdk5-p25 as a key element linking amyloid and tau pathologies in Alzheimer's disease: Mechanisms and possible therapeutic interventions","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2022.120986","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"120986"}}